173 related articles for article (PubMed ID: 25806105)
1. Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.
Muthuswamy R; Wang L; Pitteroff J; Gingrich JR; Kalinski P
J Immunother Cancer; 2015; 3():6. PubMed ID: 25806105
[TBL] [Abstract][Full Text] [Related]
2. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
[TBL] [Abstract][Full Text] [Related]
3. NFκB-Activated COX2/PGE
Ibrahim OM; Basse PH; Jiang W; Guru K; Chatta G; Kalinski P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809455
[TBL] [Abstract][Full Text] [Related]
4. NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.
Muthuswamy R; Berk E; Junecko BF; Zeh HJ; Zureikat AH; Normolle D; Luong TM; Reinhart TA; Bartlett DL; Kalinski P
Cancer Res; 2012 Aug; 72(15):3735-43. PubMed ID: 22593190
[TBL] [Abstract][Full Text] [Related]
5. Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment.
Theodoraki MN; Yerneni S; Sarkar SN; Orr B; Muthuswamy R; Voyten J; Modugno F; Jiang W; Grimm M; Basse PH; Bartlett DL; Edwards RP; Kalinski P
Cancer Res; 2018 Aug; 78(15):4292-4302. PubMed ID: 29853604
[TBL] [Abstract][Full Text] [Related]
6. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
Gandhi S; Opyrchal M; Grimm MJ; Slomba RT; Kokolus KM; Witkiewicz A; Attwood K; Groman A; Williams L; Tarquini ML; Wallace PK; Soh KT; Minderman H; Maguire O; O'Connor TL; Early AP; Levine EG; Kalinski P
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963636
[TBL] [Abstract][Full Text] [Related]
7. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.
McIlroy A; Caron G; Blanchard S; Frémaux I; Duluc D; Delneste Y; Chevailler A; Jeannin P
Immunology; 2006 Apr; 117(4):507-16. PubMed ID: 16556265
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.
Luo Y; Chen X; O'Donnell MA
Clin Exp Immunol; 2007 Feb; 147(2):370-8. PubMed ID: 17223980
[TBL] [Abstract][Full Text] [Related]
9. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.
Liu J; Li F; Ping Y; Wang L; Chen X; Wang D; Cao L; Zhao S; Li B; Kalinski P; Thorne SH; Zhang B; Zhang Y
Oncotarget; 2015 Sep; 6(28):24978-89. PubMed ID: 26317795
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
Riezu-Boj JI; Larrea E; Aldabe R; Guembe L; Casares N; Galeano E; Echeverria I; Sarobe P; Herrero I; Sangro B; Prieto J; Lasarte JJ
J Hepatol; 2011 Mar; 54(3):422-31. PubMed ID: 21129807
[TBL] [Abstract][Full Text] [Related]
11. Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.
Orr B; Mahdi H; Fang Y; Strange M; Uygun I; Rana M; Zhang L; Suarez Mora A; Pusateri A; Elishaev E; Kang C; Tseng G; Gooding W; Edwards RP; Kalinski P; Vlad AM
Clin Cancer Res; 2022 May; 28(10):2038-2049. PubMed ID: 35046055
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.
Suttmann H; Riemensberger J; Bentien G; Schmaltz D; Stöckle M; Jocham D; Böhle A; Brandau S
Cancer Res; 2006 Aug; 66(16):8250-7. PubMed ID: 16912205
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
Gandhi NM; Morales A; Lamm DL
BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
[TBL] [Abstract][Full Text] [Related]
14. Irradiation Mediates
Cheng CC; Chang YF; Ho AS; Sie ZL; Chang JS; Peng CL; Chang CC
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680466
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor.
Le Noci V; Sommariva M; Tortoreto M; Zaffaroni N; Campiglio M; Tagliabue E; Balsari A; Sfondrini L
Oncoimmunology; 2016; 5(11):e1234571. PubMed ID: 27999750
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
17. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
18. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.
Rudd BD; Burstein E; Duckett CS; Li X; Lukacs NW
J Virol; 2005 Mar; 79(6):3350-7. PubMed ID: 15731229
[TBL] [Abstract][Full Text] [Related]
19. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
Dürr C; Pfeifer D; Claus R; Schmitt-Graeff A; Gerlach UV; Graeser R; Krüger S; Gerbitz A; Negrin RS; Finke J; Zeiser R
Cancer Res; 2010 Dec; 70(24):10170-81. PubMed ID: 21159639
[TBL] [Abstract][Full Text] [Related]
20. The lymphoid chemokine CCL21 enhances the cytotoxic T lymphocyte-inducing functions of dendritic cells.
Hong CY; Lee HJ; Kim HJ; Lee JJ
Scand J Immunol; 2014 Mar; 79(3):173-80. PubMed ID: 24383579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]